Consideration surrounding incidental findings throughout multigene panel testing in cancer genetics

Clin Genet. 2016 Feb;89(2):267-8. doi: 10.1111/cge.12672. Epub 2015 Oct 6.

Authors

P Grandval^{1

2}, A J Fabre^{1

3}, C Béroud^{1

2

4}, S Olschwang^{1

3

5

6}

Affiliations

¹ INSERM UMR_S910, Medicine Faculty, Marseille, France.
² Gastroenterology Department, AP-HM Timone, Marseille, France.
³ Medical Genetics Department, AP-HM Timone, Marseille, France.
⁴ GMGF, Aix-Marseille University, Marseille, France.
⁵ Générale de Santé, Hôpital Clairval, Marseille, France.
⁶ Fondation Ambroise Paré, Hôpital Européen, Marseille, France.

PMID: 26437750
DOI: 10.1111/cge.12672

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Genes, Neoplasm*
Genetic Testing / methods*
Humans
Incidental Findings*
MutS Homolog 2 Protein / genetics
Mutation / genetics
Neoplasms / genetics*

Substances

MSH2 protein, human
MutS Homolog 2 Protein